Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Comprehensive Loss

v2.4.0.6
Consolidated Statements of Comprehensive Loss (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Revenues    
Product $ 12,897 $ 11,494
Product licensing fees 1,686 359
Service 869 891
Total revenues 15,452 12,744
Cost of revenues    
Product 3,976 3,254
Service 733 776
Total cost of revenues 4,709 4,030
Gross profit 10,743 8,714
Operating expenses    
Research and development 2,223 1,981
Selling, general and administrative 11,894 13,200
Total operating expenses 14,117 15,181
Loss from operations (3,374) (6,467)
Interest expense (1,107) (931)
Interest income 7 4
Loss due to change in fair value of common stock (See Note 9) (1,599) 0
Gain due to change in fair value of derivative liabilities 767 282
Other expense, net (125) (217)
Net loss (5,431) (7,329)
Preferred stock deemed dividend 1,062 0
Net loss available to common shareholders (6,493) (7,329)
Net loss per common share: basic and diluted $ (1.3) $ (1.87)
Weighted-average number of shares used in per common share calculations:    
Basic and diluted 4,977 3,912
Other comprehensive loss    
Net loss (5,431) (7,329)
Foreign currency translation adjustments 62 (152)
Comprehensive loss $ (5,369) $ (7,481)